Brinzolamide CAS 138890-62-7: Your Trusted Source for Ophthalmic Solutions

Discover the efficacy of Brinzolamide, a leading carbonic anhydrase inhibitor crucial for managing ocular hypertension and glaucoma. Explore our high-purity pharmaceutical intermediate, manufactured to the highest standards by a leading supplier in China.

Get a Quote & Sample

Key Product Advantages

Therapeutic Efficacy

Brinzolamide, a potent carbonic anhydrase inhibitor, is essential for patients seeking to reduce intraocular pressure, a critical step in preventing vision loss associated with glaucoma.

High-Quality Manufacturing

Our commitment to excellence as a manufacturer in China ensures that our Brinzolamide meets the highest industry standards for purity and consistency.

Global Accessibility

We offer flexible transportation and Incoterm options, making it easy for global clients to buy Brinzolamide and secure their supply chain needs.

Key Applications

Glaucoma Management

Brinzolamide is a cornerstone in treating open-angle glaucoma, effectively lowering eye pressure to protect the optic nerve and preserve vision.

Ocular Hypertension Treatment

This carbonic anhydrase inhibitor is ideal for patients experiencing elevated intraocular pressure, a precursor to glaucoma.

Ophthalmic Drug Formulation

As a high-grade pharmaceutical intermediate, Brinzolamide is used in the formulation of specialized ophthalmic solutions designed for eye care.

API Synthesis

Brinzolamide serves as a critical building block in the synthesis of active pharmaceutical ingredients for various eye care medications.